Siskind DJ, Russell AW, Gamble C, Winckel K, Mayfield K, Hollingworth S, et al
Liraglutide is additionally approved for the treatment of obesity, at a dose of 3.0 mg (128), while semaglutide is in clinical development as a treatment for obesity (phase 3) and NASH (phase 2)
Med Cell Longev (2018) 2018:110
The benefits extend far beyond just eating less
While Mounjaro is not a magic bullet, it certainly can be a game changer in overcoming barriers with weight loss & metabolic health
(Note: compounded medications are prepared by licensed pharmacies and are not FDA-approved.) Sources Water: How much should you drink every day